Septerna, Inc. Common Stock (SEPN)

PHARMACEUTICAL PREPARATIONS

Septerna, Inc. Common Stock (SEPN) is listed on Nasdaq, where it has traded since October 25, 2024.

Listed On
Nasdaq
Listed Since
October 25, 2024
Employees
130
Market Cap
$1.8B

About Septerna, Inc. Common Stock

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Institutional ownership

In 13F filings for the quarter ended September 30, 2026, 4 institutions reported holding SEPN, with 1,745 shares worth $68,282 in aggregate. The largest reported holder was Gamma Investing, with 1,378 shares worth $53,921. Of the 4 largest holders listed below, 1 opened a new position in SEPN, 1 added shares and 2 held their positions unchanged during the quarter.

InstitutionSharesValueQuarter change
Gamma Investing1,378$54KAdded 23.15%
Versant Capital Management261$10KUnchanged
Massmutual Private Wealth & Trust, Fsb104$4KUnchanged
Farther Finance Advisors2$78New position

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is SEPN?

Septerna, Inc. Common Stock (SEPN) is listed on Nasdaq, where it has traded since October 25, 2024.

Who are the largest institutional holders of SEPN?

In 13F filings for the quarter ended September 30, 2026, the largest reported holders of SEPN were Gamma Investing, Versant Capital Management and Massmutual Private Wealth & Trust, Fsb.

How many institutions own SEPN?

4 institutions reported a position in SEPN for the quarter ended September 30, 2026, worth $68,282 in total.

Did institutions buy or sell SEPN last quarter?

Of the 4 largest reported holders, 1 opened a new position in SEPN, 1 added shares and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for SEPN.

Every reported institutional holder, plus insider and congressional trades in SEPN, on SentiSense.